| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Boudreau Philip P | EVP AND CFO | 100 ABBOTT PARK ROAD, ABBOTT PARK | /s/ Philip P. Boudreau, by Jessica H. Paik, Attorney-in-Fact | 26 Feb 2026 | 0001805099 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ABT | Common shares without par value | Award | $0 | +27,997 | +55% | $0.000000 | 78,613 | 24 Feb 2026 | Direct | F1 |
| holding | ABT | Common shares without par value | 366 | 24 Feb 2026 | Profit Sharing Trust | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ABT | Option (right to buy) | Award | $0 | +115,413 | $0.000000 | 115,413 | 24 Feb 2026 | Common Shares | 115,413 | $114.60 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes. |
| F2 | Balance in the Abbott Laboratories Stock Retirement Trust as of February 24, 2026. |
| F3 | Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 38,471 on February 24, 2027, 38,471 on February 24, 2028, and 38,471 on February 24, 2029. |